Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124571165 | 12457116 | 5 | F | 20150908 | 20160708 | 20160610 | 20160715 | EXP | PHHY2016DE063023 | NOVARTIS | 64.00 | YR | F | Y | 62.50000 | KG | 20160715 | OT | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124571165 | 12457116 | 1 | SS | PAZOPANIB | PAZOPANIB | 1 | Oral | 400 MG, QD | 34800 | MG | Y | 0 | 400 | MG | TABLET | QD | |||
| 124571165 | 12457116 | 2 | PS | AFINITOR | EVEROLIMUS | 1 | Oral | 10 MG, QD | 270 | MG | 22334 | 10 | MG | QD | |||||
| 124571165 | 12457116 | 3 | C | PIPERACILLIN | PIPERACILLIN | 1 | Intravenous (not otherwise specified) | 4 G/ 50 ML, QID | Y | 0 | BID | ||||||||
| 124571165 | 12457116 | 4 | C | TAZOBACTAM | TAZOBACTAM | 1 | Intravenous (not otherwise specified) | 0.5 G/ 50 ML, BID | Y | 0 | .5 | G | BID | ||||||
| 124571165 | 12457116 | 5 | C | HYDROCORTISONE. | HYDROCORTISONE | 1 | Oral | 10 MG, (2.5-0-1) | Y | 0 | 10 | MG | |||||||
| 124571165 | 12457116 | 6 | C | HYDROCORTISONE. | HYDROCORTISONE | 1 | Oral | 25 MG, QD | Y | 0 | 25 | MG | QD | ||||||
| 124571165 | 12457116 | 7 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Oral | 10 MG, QD | Y | 0 | 10 | MG | QD | ||||||
| 124571165 | 12457116 | 8 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Oral | 5 MG, QD | Y | 0 | 5 | MG | QD | ||||||
| 124571165 | 12457116 | 9 | C | BELOC-ZOK COMP | HYDROCHLOROTHIAZIDEMETOPROLOL SUCCINATE | 1 | Oral | 47.5 MG, BID | Y | 0 | 47.5 | MG | BID | ||||||
| 124571165 | 12457116 | 10 | C | NEPRESOL | DIHYDRALAZINE SULFATE | 1 | Oral | 12.5 MG, QID | U | 0 | 12.5 | MG | QID | ||||||
| 124571165 | 12457116 | 11 | C | NEPRESOL | DIHYDRALAZINE SULFATE | 1 | Oral | 12.5 MG, (1/2 DF FOUR TIMES) | U | 0 | 12.5 | MG | |||||||
| 124571165 | 12457116 | 12 | C | MINOXIDIL. | MINOXIDIL | 1 | Oral | 02.5 MG, QD | U | 0 | 2.5 | MG | QD | ||||||
| 124571165 | 12457116 | 13 | C | DREISAVIT N | 2 | Oral | UNK UNK, QD | Y | 0 | QD | |||||||||
| 124571165 | 12457116 | 14 | C | SEVELAMER | SEVELAMER | 1 | Oral | 800 MG, TID | U | 0 | 800 | MG | TID | ||||||
| 124571165 | 12457116 | 15 | C | SILAPO | 2 | Oral | 4000 IE, QW2 | Y | 0 | BIW | |||||||||
| 124571165 | 12457116 | 16 | C | FERRLECIT | SODIUM FERRIC GLUCONATE COMPLEX | 1 | Oral | 62.5 MG, QW | Y | 0 | 62.5 | MG | /wk | ||||||
| 124571165 | 12457116 | 17 | C | SALBUTAMOL | ALBUTEROL | 1 | Respiratory (inhalation) | 1.25 MG, Q4H | Y | 0 | 1.25 | MG | Q4H | ||||||
| 124571165 | 12457116 | 18 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | Unknown | 40 MG, QD | U | 0 | 40 | MG | QD | ||||||
| 124571165 | 12457116 | 19 | C | MARCUMAR | PHENPROCOUMON | 1 | Unknown | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124571165 | 12457116 | 1 | Metastatic renal cell carcinoma |
| 124571165 | 12457116 | 2 | Metastatic renal cell carcinoma |
| 124571165 | 12457116 | 3 | Product used for unknown indication |
| 124571165 | 12457116 | 4 | Pneumonitis |
| 124571165 | 12457116 | 5 | Product used for unknown indication |
| 124571165 | 12457116 | 7 | Hypertension |
| 124571165 | 12457116 | 9 | Hypertension |
| 124571165 | 12457116 | 10 | Hypertension |
| 124571165 | 12457116 | 12 | Alopecia |
| 124571165 | 12457116 | 13 | Hypovitaminosis |
| 124571165 | 12457116 | 14 | Product used for unknown indication |
| 124571165 | 12457116 | 15 | Product used for unknown indication |
| 124571165 | 12457116 | 16 | Product used for unknown indication |
| 124571165 | 12457116 | 17 | Product used for unknown indication |
| 124571165 | 12457116 | 18 | Product used for unknown indication |
| 124571165 | 12457116 | 19 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124571165 | 12457116 | OT |
| 124571165 | 12457116 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124571165 | 12457116 | Abdominal pain upper | |
| 124571165 | 12457116 | Arrhythmia | |
| 124571165 | 12457116 | Atrial fibrillation | |
| 124571165 | 12457116 | Cardiac failure | |
| 124571165 | 12457116 | Chest pain | |
| 124571165 | 12457116 | Diarrhoea | |
| 124571165 | 12457116 | Dyspnoea | |
| 124571165 | 12457116 | Fatigue | |
| 124571165 | 12457116 | Malignant neoplasm progression | |
| 124571165 | 12457116 | Nausea | |
| 124571165 | 12457116 | Night sweats | |
| 124571165 | 12457116 | Palpitations | |
| 124571165 | 12457116 | Pericardial effusion | |
| 124571165 | 12457116 | Pneumonitis | |
| 124571165 | 12457116 | Pyrexia | |
| 124571165 | 12457116 | Toothache | |
| 124571165 | 12457116 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124571165 | 12457116 | 1 | 20150825 | 20151119 | 0 | |
| 124571165 | 12457116 | 2 | 20151120 | 20160126 | 0 | |
| 124571165 | 12457116 | 3 | 20160124 | 20160131 | 0 | |
| 124571165 | 12457116 | 4 | 20160124 | 20160131 | 0 | |
| 124571165 | 12457116 | 5 | 201308 | 0 | ||
| 124571165 | 12457116 | 6 | 201605 | 0 | ||
| 124571165 | 12457116 | 7 | 2013 | 0 | ||
| 124571165 | 12457116 | 9 | 2013 | 0 | ||
| 124571165 | 12457116 | 13 | 201308 | 201605 | 0 | |
| 124571165 | 12457116 | 15 | 201308 | 201605 | 0 | |
| 124571165 | 12457116 | 16 | 201308 | 201605 | 0 | |
| 124571165 | 12457116 | 17 | 20160124 | 20160131 | 0 | |
| 124571165 | 12457116 | 19 | 20151022 | 0 |